Enoxaparin sodium is a low molecular weight heparin preparation, clinically known as low molecular weight heparin, has strong antithrombotic and thrombolysis effects, used to prevent deep vein thrombosis and pulmonary embolism. Treatment of existing venous thrombosis; Prevention of thrombosis in cardiopulmonary bypass during hemodialysis; Clinical use of enoxaparin sodium for unstable angina pectoris and non - Q - wave myocardial infarction.

　　Enoxaparin sodium is usually administered at 1mg/kg subcutaneously every 12 hours or intravenously when a load dose is administered. For the elderly and patients with renal failure, attention should be paid to appropriate dosage reduction.

　　Clinical enoxaparin sodium is mainly used to prevent postoperative venous thrombosis, prevent deep venous thrombosis, and treat pulmonary embolism, deep venous thrombosis and acute coronary syndrome. The biggest complication of enoxaparin sodium is bleeding complication. Qingdao Jiulong Medicine is the manufacturer of Enoxaparin Sodium API, welcome to consult!